Professional Documents
Culture Documents
Review
Rapid tests for diagnosis of leptospirosis: Current tools and emerging technologies
Mathieu Picardeau a, Eric Bertherat b, Michel Jancloes c, Andreas N. Skouloudis d,
Kara Durski b, Rudy A. Hartskeerl e,
a
Institut Pasteur, Unit de Biologie des Spirochtes, National Reference Center and WHO Collaborating Center for Leptospirosis, Paris, France
World Health Organization, Health Security and Environment/Pandemic and Epidemic Diseases, 20 Av Appia, 1211, Geneva 27, Switzerland
Health and Climate Foundation, 1425K St NW suite 350, Washington DC 20005, USA
d
Institute for Environment and Sustainability, Joint Research Centre, European Commission, Ispra VA, Italy
e
Royal Tropical Institute, KIT Biomedical Research, WHO/FAO/OIE and National Collaborating Centre for Reference and Research on Leptospirosis, Amsterdam, The Netherlands
b
c
a r t i c l e
i n f o
Article history:
Received 23 July 2013
Received in revised form 9 September 2013
Accepted 15 September 2013
Available online 1 October 2013
Keywords:
Leptospirosis
Diagnostics
Outbreak
Surveillance
Diagnostic test
Early warning
Early diagnosis
Innovation
a b s t r a c t
Leptospirosis is an emerging zoonosis with a worldwide distribution but is more commonly found in
impoverished populations in developing countries and tropical regions with frequent ooding. The rapid
detection of leptospirosis is a critical step to effectively manage the disease and to control outbreaks in both
human and animal populations. Therefore, there is a need for accurate and rapid diagnostic tests and
appropriate surveillance and alert systems to identify outbreaks. This review describes current in-house
methods and commercialized tests for the rapid diagnosis of acute leptospirosis. It focuses on diagnostic tests
that can be performed with minimal training and limited equipment in less-developed and newly
industrialized countries, particularly in resource-limited settings and with results in minutes to less than 4
hours. We also describe recent technological advances in the eld of diagnostic tests that could allow for the
development of innovative rapid tests in the near future.
2014 Elsevier Inc. All rights reserved.
1. Introduction
Leptospirosis is of particular public health concern due to its
global distribution, its epidemic potential, its presence in animals
and the natural environment, and its high potential for human
mortality, if left untreated. A World Health Organization (WHO)
lead experts' group estimated the global burden of leptospirosis to
be 873,000 severe annual cases and 49,000 deaths (http://www.
who.int/zoonoses/diseases/lerg/en/index.html). The recent outbreaks of leptospirosis in the South East Asia have increased the
awareness of the need for improved diagnostic tests for leptospirosis (Agampodi et al., 2011; Amilasan et al., 2012). Leptospirosis is
also one of the most important zoonotic diseases over the world.
Human infection results from contacts with carrier animals or
environment contaminated with leptospires. It is a major environmental endemic disease with increased threat of severe epidemics
often linked with natural disasters such as oods and hurricanes
(Lau et al., 2010; Levett, 2001).
Because there is much overlap in the clinical presentation of
undifferentiated febrile illnesses, which includes leptospirosis, malaria, rickettsioses, and arboviral diseases, it is not possible to reliably
The choice for the use of a diagnostic test will depend on a number
of factors, including its diagnostic accuracy, nancial feasibility,
baseline data on the local epidemiology is critical for the interpretation of test results or for the prediction, prevention, or early
intervention of outbreaks. For adequate surveillance of leptospirosis,
the availability of diagnostic tests is pivotal. The higher the diagnostic
accuracy of the test, the better it is for surveillance, although any type
of diagnostic test might be helpful for this purpose, provided that its
performance has been well assessed.
from urine 1014 days after the onset of symptoms albeit that this
does not contribute to an early diagnosis (Levett, 2001).
The nucleic acidbased diagnostic tests involve nucleic acid
purication. Commercially available kits usually allow a good
recovery of DNA from blood within less than 1 hour (Bourhy et al.,
2011). The use of magnetic beads allows concentration of nucleic acid
or antigens in samples (Schreier et al., 2012; Taylor et al., 1997). To
simplify DNA extraction procedures, use of whole blood spotted on
Whatman FTA lter paper, which is a chemically treated lter paper,
can allow for the rapid isolation of pure DNA. Similarly, serological
studies can be performed from dried whole blood spotted onto
Whatman lter paper (Desvars et al., 2011). These commercially
available reagents are an easy and inexpensive means for the
collection and storage of samples in resource-limited settings or for
the shipment of samples to reference centres.
4. Current diagnostic tools
As current diagnostic tools, we consider the direct examination
of blood, the rapid nucleic-acid diagnosis, and rapid antibodybased tests.
4.1. Direct examination of blood
The bacterial load in blood ranges from 10 2 to 10 6 Leptospira per
millilitre (Agampodi et al., 2012) in the acute phase. In theory,
leptospirosis can therefore be diagnosed by dark-eld microscopy of
blood taken during the rst week of illness. The limit of detection was
determined as approximately 10 4 leptospires per millilitre of blood or
urine (Table 2). Although it is relatively inexpensive, this test
requires a dark-eld microscope, which is rarely available or
affordable in resource-limited settings. Dark-eld microscopy of
blood is unreliable as Brownian movement of collagen brils, red
blood cell membranes, and other artefacts can resemble viable
leptospires (Vijayachari et al., 2001).
4.2. Rapid nucleic acidbased diagnostic test
4.2.1. Polymerase chain reaction
PCR-based methods are becoming more widely used for the
detection of pathogenic Leptospira strains, in part because of their
superior sensitivity and ability to establish an early diagnosis. Realtime PCR, either using SYBR Green or Taqman technology, has the
advantage that it gives a result much faster than conventional PCR and
is less prone to contamination. The commercialization of portable PCR
thermocyclers compatible with real-time PCR chemistries may also
allow the rapid detection of pathogens in the eld.
Several conventional (including nested PCR) and real-time PCRs
have been developed for the detection of leptospires, targeting whole
arrays of genes, whether or not conned to pathogenic species,
exemplied by secY and lipL32, respectively. However, relatively few
assays have been validated for use with a variety of human and
canine samples (Ahmed et al., 2012; Ahmed et al.; Slack et al., 2007;
Thaipadungpanit et al., 2011; Villumsen et al., 2012). This is
surprising because a good diagnostic accuracy as revealed by a solid
validation should be the prime criterion of choice for implementing a
diagnostic PCR. The limit of detection of PCR assays was generally
determined as 1001000 bacteria per millilitre of blood or urine
(Bourhy et al., 2011; Slack et al., 2006; Smythe et al., 2002; Stoddard
et al., 2009). Bacterial load may be obtained if quantitative standards
are included in the amplication run and a standard curve has been
produced. However, this may not be informative as the quantitative
leptospiremia was not always correlated with the vital prognosis of
patients (Agampodi et al., 2012; Segura et al., 2005; Truccolo et al.,
2001). A positive PCR usually indicates that one of the members of the
pathogenic Leptospira species is present in the sample but PCR cannot
Table 1
Commercial tests used for the diagnosis of acute leptospirosis.
Test/kit
Manufacturer
Technology
ELISA
ELISA
ELISA
ELISA
ELISA
ELISA
ELISA
IHA
Indirect hemagglutination test
Microcapsule agglutination test
LFA
LFA
LFA
LFA
LFA
Latex card-agglutination test
Latex card-agglutination test
Real-time PCR
Real time-PCR
Real time-PCR
a
b
1966). The antigen should consist of all locally prevalent strains or,
alternatively, the saprophyte L. biexa serovar Patoc, which shares
many surface antigens with pathogenic strains. A drop of serum is
mixed on a glass plate with the antigen, briey incubated at ambient
temperature and inspected by naked eye for presence of agglutination. The MSAT is relatively insensitive for diagnosis but may be useful
for epidemiological screening (Marin-Leon et al., 1997).
IHA uses red blood cells sensitized with an extract of an
erythrocyte-sensitizing substance from L. biexa serovar Patoc
(Chang et al., 1957; McComb et al., 1957). IHA detects both IgM
and IgG antibodies. Heat-inactivated serum is mixed with sensitized
red blood cells, and agglutination is examined by the naked eye.
Estimates of the sensitivity of the IHA in populations in which
leptospirosis is endemic have varied from good (Levett and
Whittington, 1998) to poor (Efer et al., 2000), possibly because
of differences in case ascertainment and study design, including
inclusion of epidemiological distinct populations and the unavailability of prospective unbiased samples (Hull-Jackson et al., 2006;
McBride et al., 2007).
Table 2
Performance of rapid diagnostic tests during the acute phase of leptospirosis.
Test
Approximate
cost a
Execution time
Equipment
Sensitivityb
Specicity
Optimal detection
windowc
Direct examination
b 1
15 min
low
Early acute
Commercialized
IgM ELISA
In house IgM ELISA
816
12 h
104/mLd
(analytical)
N90%
8895%
24 h
93%
98-100%
81%
96%
LFA
25
1520 min
Cold room/refrigerator
Conventional PCR
68
90100%
68
60100%
Real-time PCR
60100%
90100%
Early acute
Isothermal method
1015
5 h (including DNA
extraction with a kit)
2 h (including DNA
extraction with a kit)
2 h (including DNA
extraction with a kit)
Late acute to
convalescent
Late acute to
convalescent
Late acute to
convalescent
Early acute
Less than
PCR
Early acute
The generalized data on costs and diagnostic accuracy listed in this table, in part, summarize the data presented by Hartskeerl et al. (2011).
a
Direct costs, not including use of DNA extraction kit, salaries, equipment, etc., but dependent on local import taxes.
b
First 10 days after the onset of symptoms, depending on the stage of disease.
c
Optimal sensitivity expressed in phase of disease: early acute is 5 DPO, late acute is 510 DPO, convalescent is N10 DPO.
d
From Levett, 2001.
e
Several novel LFAs can be stored for months at ambient temperature.